Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

View basket
☰

Venlafaxine

Venlafaxine
In stock
37,5mg · 75mg
from 18,34 £
Strength
Pack size — the bigger the pack, the cheaper the tablet
39,44 £34,40 £
1,15 £ per tablet

In brief

  • Venlafaxine is an SNRI antidepressant used for major depression and, after recovery, to reduce the risk of another episode.
  • Choose 37.5 mg (30 to 360 tablets) or 75 mg (10 to 360 tablets).
  • Prescription-only in the UK, where tablets, oral solutions and prolonged-release forms such as Efexor XL are licensed.

Venlafaxine: serotonin and noradrenaline together

Venlafaxine works on two chemical messengers at once, serotonin and noradrenaline, which is why it is called an SNRI. By blocking their reuptake in the brain, it leaves more of them available between nerve cells, which over several weeks can lift mood, energy and sleep in people with depression. In the UK, the standard tablets are licensed to treat episodes of major depression and, once someone has responded, to lower the chance of relapse. Improvement is gradual rather than immediate, so it is worth continuing as prescribed even if the first weeks feel slow.

37.5 mg and 75 mg tablet counts

For 37.5 mg you can choose 30, 60, 90, 120, 180, 240 or 360 tablets; the 75 mg version adds a 10-tablet option to the same range. These are imported products, so look at the pack to see whether the tablets are standard or prolonged-release, because the two are taken differently and are not interchangeable without advice.

How the dose is set

For the standard tablets, the SmPC starts adults on 75 mg daily, divided into two doses and taken with meals. If there is no response, the dose can be raised in steps normally at least two weeks apart (or, if clinically needed, no less than four days apart), up to a ceiling of 375 mg a day. Once symptoms have settled, the SmPC expects treatment to carry on for a minimum of six months. The dose is cut by half for mild to moderate liver impairment and for kidney function below a GFR of 30 ml/min or haemodialysis. Use in those under 18 is not recommended. Swallow standard tablets with a drink; prolonged-release products are taken once a day and must not be crushed or chewed.

Reducing the dose at the end of treatment

Stopping abruptly often causes discontinuation symptoms: dizziness, odd sensations such as electric-shock feelings, disturbed sleep, agitation or anxiety, nausea and headache. Venlafaxine should be withdrawn over a minimum of one to two weeks, according to the SmPC, and for some people the reduction stretches over months. If symptoms become hard to tolerate, the previous dose may be resumed and then lowered more slowly.

Licensed products in the UK

All UK venlafaxine products are prescription-only (POM). Besides standard tablets there are oral solutions and prolonged-release capsules and tablets, including the Efexor XL brand. Certain prolonged-release brands extend the licence to anxiety: generalised anxiety disorder, social anxiety disorder and panic disorder.

Interactions, checks and common effects

Venlafaxine is never taken alongside an irreversible MAOI: allow 14 days after stopping one before starting, and seven days in the other direction. Serotonin syndrome becomes more likely when it is combined with moclobemide, linezolid, a triptan, lithium, tramadol, St John’s wort or any other medicine that boosts serotonin. Blood pressure should be measured before treatment and monitored, as it can rise with dose. Take care with heart disease, epilepsy, angle-closure glaucoma, a history of mania, or a bleeding tendency or anticoagulant use. Blood sodium can drop, mainly in older people, and under-25s need close watching for suicidal thoughts early on. Common effects include nausea, dry mouth, headache, sweating, dizziness, constipation and sleep changes. Avoid alcohol. Your doctor decides whether venlafaxine suits you.

Related products